Herzig S, Heber D, Mescheder A, Reifenstein-Herzig U, Thormann T, Verborg M, Mohr K
Institute of Pharmacology, University of Kiel, Fed. Rep. of Germany.
Arzneimittelforschung. 1994 Aug;44(8):937-42.
The positive inotropic effect of a series of 4-amino-7-methyl-1,8-naphthyridine-3-carboxylic acid derivatives was compared with the effects of known inotropic agents (ouabain, dihydroouabain, isoproterenol, adrenaline, histamine and isobutylmethylxanthine) in guinea-pig atrial and ventricular myocardial preparations. With respect to their functional effects, the 1,8-naphthyridine compounds are clearly different from drugs acting on the cAMP system, whereas several similarities with cardiac glycoside effects were found. Their ability to inhibit [3H]ouabain binding in guinea-pig cardiac membranes correlates well with their effects on myocardial contractile force. However, the latter effect was exerted by tenfold lower concentrations. The dissimilarities found between the 1,8-naphthyridines and digitalis may be due to a different type of interaction with the binding site on the (Na(+) + K+)-ATPase.
在豚鼠心房和心室心肌标本中,比较了一系列4-氨基-7-甲基-1,8-萘啶-3-羧酸衍生物的正性肌力作用与已知正性肌力药物(哇巴因、双氢哇巴因、异丙肾上腺素、肾上腺素、组胺和异丁基甲基黄嘌呤)的作用。就其功能效应而言,1,8-萘啶化合物与作用于环磷酸腺苷(cAMP)系统的药物明显不同,而与强心苷的效应有若干相似之处。它们抑制豚鼠心脏膜中[3H]哇巴因结合的能力与其对心肌收缩力的作用密切相关。然而,产生后一种效应所需的浓度要低十倍。1,8-萘啶与洋地黄之间的差异可能是由于与(Na(+) + K+)-ATP酶结合位点的相互作用类型不同所致。